Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Post by Mt69sinaion Oct 15, 2020 8:45am
219 Views
Post# 31719962

BRIEF-Aphria Reports Q1 Loss Per Share Of $0.02

BRIEF-Aphria Reports Q1 Loss Per Share Of $0.02
BRIEF-Aphria Reports Q1 Loss Per Share Of $0.02 

Reuters - Updated just now

Oct 15 (Reuters) - Aphria Inc:

* . ANNOUNCES RECORD ADULT-USE CANNABIS GROSS REVENUE IN FIRST QUARTER FISCAL YEAR 2021 AND SIXTH CONSECUTIVE QUARTER OF POSITIVE ADJUSTED EBITDA

* QTRLY NET CANNABIS REVENUE INCREASED 103% FROM PRIOR YEAR QUARTER

* QTRLY NET REVENUE OF $145.7 MILLION IN Q1, AN INCREASE OF 16% FROM PRIOR YEAR QUARTER

* QTRLY NET CANNABIS REVENUE OF $62.5 MILLION IN Q1, AN INCREASE OF 103% FROM PRIOR YEAR QUARTER

* AVERAGE RETAIL SELLING PRICE OF MEDICAL CANNABIS, BEFORE EXCISE TAX, INCREASED TO $7.38 PER GRAM IN QUARTER

* QTRLY LOSS PER SHARE $0.02

* Q1 REVENUE VIEW C$159.7 MILLION -- REFINITIV IBES DATA

* Q1 EARNINGS PER SHARE VIEW C$-0.04 -- REFINITIV IBES DATA Source text for Eikon: Further company coverage:

$$$$APHA$$$$


<< Previous
Bullboard Posts
Next >>